Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Current Opinion in Biotechnology|December 23, 2023
Breaking tolerance: autoantibodies can target protein posttranslational modificationsKristin J Lastwika, Paul D LampeJournal of Cell Science|August 21, 2019
Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repairKristin J Lastwika, Clarence A Dunn, Joell L Solan, et al.Journal of Proteome Research|October 23, 2016
Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with ObesityCarly B Garrison, Kristin J Lastwika, Yuzheng Zhang, et al.European Radiology|May 23, 2019
Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control studyWei Wu, Larry A Pierce, Yuzheng Zhang, et al.Molecular Pharmaceutics|February 8, 2024
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung CancerSamantha M Sarrett, Cindy Rodriguez, Samantha Delaney, et al.Cancers|July 14, 2023
Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk AssessmentKristin J Lastwika, Wei Wu, Yuzheng Zhang, et al.American Journal of Respiratory and Critical Care Medicine|November 14, 2018
Tumor-derived Autoantibodies Identify Malignant Pulmonary NodulesKristin J Lastwika, Julia Kargl, Yuzheng Zhang, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 28, 2022
CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung CancerAndrew G Kunihiro, Samantha M Sarrett, Kristin J Lastwika, et al.Cell Communication & Adhesion|December 19, 2003
Identification of connexin-43 interacting proteinsDeepika Singh, Paul D LampeGenes & Cancer|January 4, 2014
Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf lossGemma L Robinson, James P Robinson, Kristin J Lastwika, et al.Pageof 15